Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Cluster_Neurowissenschaften_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
  • Research
  • Education
  • Press Review
 
Neuroscience /
 
Subnavigation
    News
     

    Vienna as the international research centre for ultrasound brain therapies

    In recent years, ultrasound brain therapies have gained importance worldwide and are considered a..

     

    Impact of the COVID pandemic on people with schizophrenia - Researchers discovered that the pandemic had a significant impact on the lives and treatment of people suffering from schizophrenic psychoses

    A research group led by Matthäus Fellinger from the Department of Psychiatry and Psychotherapy at..

     

    Psychostimulants: Cause of differences in duration and intensity of effect explored

    Psychostimulants interacting with the dopamine transporter are found in the therapy of..

     

    Gabriele Fischer nominated again for Scientific Advisory Board of the EU Drugs Monitoring Centre

    The internationally renowned addiction expert Gabriele Fischer from the University Department of..

     

    Lukas Haider awarded with the Karl-Vass-Multiple-Sclerosis research prize - Radiologist of MedUni Wien was honoured for research in the field of multiple sclerosis

    The Karl Vass Multiple Sclerosis Research Award was presented to Lukas Haider from the Department..

     

    Tweets regarding suicide prevention might prevent suicide

    A scientific team led by Thomas Niederkrotenthaler and Hannah Metzler from MedUni Vienna and..

     

    Light therapy relieves fatigue syndrome in Multiple Sclerosis

    Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is..

     
    Treffer 1 bis 7 von 172
    << Erste < Vorherige Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Nächste > Letzte >>
     
Inhaltsbereich

Light therapy relieves fatigue syndrome in Multiple Sclerosis

Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group led by Stefan Seidel from the Department of Neurology at MedUni Vienna and AKH Vienna identified light therapy as a promising non-drug treatment option: patients included in the study showed a measurable improvement after just 14 days of use. The study results were recently published in the Multiple Sclerosis Journal – Experimental, Translational and Clinical.

 

 

For the first time, Stefan Seidel's research team relied not only on surveys but also on objective measurements when selecting the test persons. For example, sleep-wake disorders were ruled out in the 26 participating MS patients, particularly with the assistance of various sleep medicine examinations. "In this manner, for example, we ensured that MS patients with fatigue do not suffer from sleep apnea or periodic leg movements during sleep. Both are sleep disorders that can lead to fatigue in everyday life," elaborated study leader Stefan Seidel.

Performance improvement
The test persons - all patients of the Neurology Department at MedUni Vienna and AKH Vienna - were equipped with commercially available light sources for self-testing at home: Half of the participants received a daylight lamp with a brightness of 10,000 lux, while the other half received an identical lamp that emitted a red light with an intensity of <300 lux due to a filter. While the red light used by the control group showed no effect, the researchers were able to observe measurable successes in the other group after only 14 days: The participants who used their 10,000 lux daylight lamp for half an hour every day showed improved physical and mental performance after only a short period of time. In addition, the group of participants who had consumed bright light displayed less daytime sleepiness in comparison with the other group.

Up to 99 percent of patients
Fatigue is a severe form of tiredness and fatigability that occurs in 75 to 99 percent of people with MS and is described as particularly distressing. Nerve damage triggered by MS is being discussed as the cause. In addition to behavioural measures, such as regular rest breaks, various medications are currently available to alleviate fatigue, but some of these are associated with severe side effects. "The findings from our study represent a promising non-drug therapeutic approach," Stefan Seidel affirms. However, the results still need to be confirmed in a subsequent larger-scale study. The exact background of the invigorating effect of light therapy on MS patients will also be the subject of further scientific research.

Publication: Multiple Sclerosis Journal – Experimental, Translational and Clinical
Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomised sham-controlled trial;
Lisa Voggenberger, Marion Böck, Doris Moser, Gudrun Lorbeer, Patrick Altmann, Fritz Leutmezer, Thomas Berger, Stefan Seidel;
doi: 10.1177/20552173221133262

 

 

zurück zu: Neuroscience
 
 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact